An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Clinical trial NCT07459660 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07459660
- Sponsor
- MapLight Therapeutics
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-25
- Primary completion
- 2029-03-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.